Meridian Medical Technologies
United States Updated 9 July 2026
Meridian Medical Technologies is a finished-dose manufacturer based in United States. It appears in 9 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with US FDA and NPRA (MY). Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 5 June 2024 as VAI.
2
registered plants
2 with an FDA FEI number
9
filings
across 2 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 5 June 2024 VAI US FDA
- 21 December 2019 OAI US FDA
- 24 March 2017 OAI US FDA
- 23 March 2015 VAI US FDA
- 25 November 2014 OAI US FDA
- 21 February 2014 OAI US FDA
- 9 October 2013 OAI US FDA
- 29 April 2013 OAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Bridgeton, United States | 3033729014 |
| St. Louis, United States | 1950222 |
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| US FDA | 7 | 1 |
| NPRA (MY) | 2 | None |
Comparing suppliers?
Choose your molecules and target markets. Meridian Medical Technologies comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 5 June 2024.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates